Editorial 商業的な転換点 2017年3月1日 Nature Biotechnology 35, 3 doi: 10.1038/nbt.3829 RNA-based therapeutics are poised to become successful commercial products, but wide adoption across the biopharmaceutical industry will likely take a few more years. Full text PDF 目次へ戻る
